STS-ACC TVT注册研究:经导管主动脉瓣置换术的演变
该注册研究收集2011至2019年美国各州276,316例TAVR患者数据,显示年手术量逐年增长并于2019年超过外科主动脉瓣置换(72,991例 vs 57,626例)。2019年股动脉入路占95.3%,住院2天,90.3%出院回家;30天死亡率由7.2%降至2.5%,卒中由2.75%降至2.3%,起搏器植入率无变化(10.9%至10.8%)。
要点
- 2019年TAVR量超过SAVR(72,991例 vs 57,626例),已覆盖全美各州。
- 30天死亡率由7.2%降至2.5%,卒中由2.75%降至2.3%。
- 起搏器植入率无改善,由10.9%至10.8%。
核心结论
- TAVR量逐年增长并于2019年超过SAVR,30天死亡率和卒中下降,但起搏器需求未改善。
研究设计与样本
- STS-ACC TVT注册研究,2011至2019年纳入美国各州276,316例TAVR患者。
主要发现
- 2019年TAVR量72,991例,超过SAVR的57,626例。
- 2019年股动脉入路增至95.3%,住院2天,90.3%出院回家。
- 30天死亡率由7.2%降至2.5%,卒中由2.75%降至2.3%。
- 起搏器植入率由10.9%至10.8%,无变化。
- 1年时8/10患者存活且患者报告结局可接受。
关键数值与推荐
- 2019年首次报告8,395例低危患者TAVR数据。
临床怎么用
- TAVR已从高危扩展至低危患者,需关注起搏器植入等未改善的结局。
局限性
- 为注册研究,未报告随机对照设计;COVID-19影响及站点表现待后续研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The STS-ACC TVT Registry (Society of Thoracic Surgeons-American College of Cardiology Transcatheter Valve Therapy Registry) from 2011 to 2019 has collected data on 276,316 patients undergoing transcatheter aortic valve replacement (TAVR) at sites in all U.S. states. Volumes have increased every year, exceeding surgical aortic valve replacement in 2019 (72,991 vs. 57,626), and it is now performed in all U.S. states. TAVR now extends from extreme- to low-risk patients. This is the first presentation on 8,395 low-risk patients treated in 2019. In 2019, for the entire cohort, femoral access increased to 95.3%, hospital stay was 2 days, and 90.3% were discharged home. Since 2011, the 30-day mortality rate has decreased (7.2% to 2.5%), stroke has started to decrease (2.75% to 2.3%), but pacemaker need is unchanged (10.9% to 10.8%). Alive with acceptable patient-reported outcomes is achieved in 8 of 10 patients at 1 year. The Registry is a national resource to improve care and analyze TAVR's evolution. Real-world outcomes, site performance, and the impact of coronavirus disease 2019 will be subsequently studied. (STS/ACC Transcatheter Valve Therapy Registry [TVT Registry]; NCT01737528).
引用
- Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. Ann Thorac Surg. 2020. PMID: 33213826. doi:10.1016/j.athoracsur.2020.09.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。